Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Atzpodien J, Kirchner H: Cancer, cytokines, and cytotoxic cells: Interleukin-2 in the immunotherapy of human neoplasms. Klin Wschr 1990;68:1–11.
2. Aulitzky W, Gastl G, Aulitzky WE, Herold M, Kemmler J, Mull B, Frick J, Huber C: Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferongamma. J Clin Oncol 1989;7:1875–1884.
3. Bono AV: Steroid hormones and hormonal treatment in renal cell carcinoma, in De Kernion, Pavone-Macaluso (eds): Tumors of the kidney, Vol 13. Baltimore, Williams & Wilkins, 1986, pp 205–227.
4. Debruyne FMJ: Interferons and tumor necrosis factor (BRMS) in the management of renal cell carcinoma, in: Immunobiology of renal cell carcinoma. Cleveland, 1989.
5. De Kernion JB, Sarna JB, Figlin R, Lindner A, Smith RB: The treatment of renal cell carcinoma with human leukocyte alpha-interferon. J. Urol 1983;130:1063–1066.